# Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

> clinical trial · VERIFIED · 2026-07-16

Status: RECRUITING · Sponsor: City of Hope Medical Center · Condition: Acute Myeloid Leukemia

- Company: City of Hope Medical Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06498973

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.